PA Good Doctor's stock price plummeted 5.19% during intraday trading on Friday.

The sharp decline followed the company's release of its first-quarter earnings report. While the report showed solid operational performance, including a 45.8% year-over-year increase in adjusted net profit, the company explicitly cautioned investors about the premium risk in its secondary market trading price. Third-party valuation estimates placed the stock's fair value significantly below its recent trading level, prompting a market correction of the accumulated valuation premium in a classic "sell-the-news" reaction.